跳至主要内容
临床试验/ISRCTN61965252
ISRCTN61965252已完成4 期

A randomized, double-blind, controlled trial to evaluate the efficacy and safety of a combination of xyloglucan and gelose associated to oral rehydration salts for the treatment of acute diarrhea in children (iDEA STUDY)

OVENTURE S.L.0 个研究点目标入组 100 人开始时间: 2020年4月24日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

2021 results in https://pubmed.ncbi.nlm.nih.gov/33028102/ (added 12/05/2021)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Acute gastroenteritis defined as a change in stool consistency according to the Bristol Stool Form (BSF) scale and/or an increase in the frequency of evacuations (typically =3 in 24 h) lasting more than 1 day and no longer than 3 days
  • 2. Age group of children between = 3 months and = 14 years
  • 3. A caregiver must provide written informed consent

排除标准

  • 1. Use of antibiotics, gelatine tannate, diosmectite, other probiotics, racecadotril, or zinc (including zinc containing ORS) within a week prior to enrolment
  • 2. Exclusive breast feeding
  • 3. Chronic diarrheal gastrointestinal disease (eg. inflammatory bowel diseases, cystic fibrosis, coeliac disease, food allergy)
  • 4. Immunodeficiencies
  • 5. Malnutrition (weight/height/length under 3rd percentile) (WHO Child Growth Standards will be used)
  • 6. If needed, discontinuation or modification of the treatment may be considered at the discretion of the physician

研究者

发起方
OVENTURE S.L.

相似试验